U
HTG Molecular Diagnostics, Inc. HTGMQ
$0.0001 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

03/31/2023 12/31/2022 09/30/2022 06/30/2022 03/31/2022
Net Income -20.15M -21.59M -22.09M -22.07M -18.79M
Total Depreciation and Amortization 487.70K 587.10K 640.00K 699.20K 708.80K
Total Amortization of Deferred Charges 366.90K 412.80K 448.00K 462.60K 464.90K
Total Other Non-Cash Items 2.62M 2.33M 1.59M 1.89M 174.30K
Change in Net Operating Assets -157.30K -143.10K -361.00K -383.10K -648.60K
Cash from Operations -16.83M -18.41M -19.77M -19.40M -18.09M
Capital Expenditure -20.90K -23.10K -76.70K -414.00K -554.30K
Sale of Property, Plant, and Equipment 104.00K 104.00K 104.00K -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 3.40M 12.34M 11.89M 7.84M 2.07M
Cash from Investing 3.48M 12.42M 11.92M 7.43M 1.51M
Total Debt Issued 822.90K 822.90K 822.90K -- --
Total Debt Repaid -7.18M -7.79M -6.77M -3.27M -2.02M
Issuance of Common Stock 9.07M 16.68M 7.98M 8.58M 12.24M
Repurchase of Common Stock -551.00K -558.90K -559.20K -519.20K -10.20K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -439.70K -553.60K -604.40K -616.10K -787.00K
Cash from Financing 1.73M 8.60M 871.10K 4.17M 9.43M
Foreign Exchange rate Adjustments 1.20K -6.30K -31.00K -23.30K -10.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -11.62M 2.61M -7.02M -7.82M -7.16M
Weiss Ratings